NCT04446351 Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04428333 Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase PHASE3
NCT04420221 Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) Status COMPLETED Phase PHASE2
NCT04398745 A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04398680 A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function Status WITHDRAWN Phase PHASE1
NCT04376684 Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease Status COMPLETED Phase PHASE2
NCT04374136 A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) Status TERMINATED Phase PHASE3
NCT04371380 Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04366349 A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants Status COMPLETED Phase PHASE1
NCT04349280 A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer Status TERMINATED Phase PHASE1
NCT04341181 ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling Status RECRUITING Phase PHASE2
NCT04333147 Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) Status TERMINATED Phase PHASE3
NCT04318548 Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age Status COMPLETED Phase PHASE3
NCT04318535 Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions Status COMPLETED Phase PHASE1
NCT04316585 A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants Status COMPLETED Phase PHASE1
NCT04313504 Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC Status COMPLETED Phase PHASE2
NCT04311463 Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants Status COMPLETED Phase PHASE1
NCT04295733 Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency Status COMPLETED Phase N/A